Literature DB >> 28249968

Defining modes of failure after joint-preserving surgery of the hip.

P E Beaulé1, H Bleeker1, A Singh1, J Dobransky1.   

Abstract

AIMS: Joint-preserving surgery of the hip (JPSH) has evolved considerably and now includes a number of procedures, including arthroscopy, surgical dislocation, and redirectional osteotomies of the femur and acetabulum. There are a number of different factors which lead to failure of JPSH. Consequently, it is of interest to assess the various modes of failure in order to continue to identify best practice and the indications for these procedures. PATIENTS AND METHODS: Using a retrospective observational study design, we reviewed 1013 patients who had undergone JPSH by a single surgeon between 2005 and 2015. There were 509 men and 504 women with a mean age of 39 years (16 to 78). Of the 1013 operations, 783 were arthroscopies, 122 surgical dislocations, and 108 peri-acetabular osteotomies (PAO). We analysed the overall failure rates and modes of failure. Re-operations were categorised into four groups: Mode 1 was arthritis progression or organ failure leading to total hip arthroplasty (THA); Mode 2 was an Incorrect diagnosis/procedure; Mode 3 resulted from malcorrection of femur (type A), acetabulum (type B), or labrum (type C) and Mode 4 resulted from an unintended consequence of the initial surgical intervention.
RESULTS: At a mean follow-up of 2.5 years, there had been 104 re-operations (10.2%) with a mean patient age of 35.5 years (17 to 64). There were 64 Mode 1 failures (6.3%) at a mean of 3.2 years following JPSH with a mean patient age of 46.8 years (18 to 64). There were 17 Mode 2 failures (1.7%) at a mean of 2.2 years post-JPSH with a mean patient age of 28.9 years (17 to 42) (2% scopes; 1% surgical dislocations). There were 19 Mode 3 failures (1.9%) at a mean of 2.0 years post-JPSH, with a mean patient age of 29.9 years (18 to 51) (2% scopes; 2% surgical dislocations; 5% PAO). There were 4 Mode 4 failures (0.4%) at a mean of 1.8 years post-JPSH with a mean patient age of 31.5 years (15 to 43). Using the modified Dindo-Clavien classification system, the overall complication rate among JPSHs was 4.2%.
CONCLUSION: While defining the overall re-operation and complication rates, it is important to define the safety and effectiveness of JPSH. Standardisation of the modes of failure may help identify the best practice. Application of these modes to large clinical series, such as registries, will assist in further establishing how to improve the efficacy of JPSH. Cite this article: Bone Joint J 2017;99-B:303-9. ©2017 The British Editorial Society of Bone & Joint Surgery.

Entities:  

Keywords:  Arthroscopy; Hip; Joint preservation; Modes of failure; Periacetabular osteotomy; Surgical dislocation

Mesh:

Year:  2017        PMID: 28249968     DOI: 10.1302/0301-620X.99B3.BJJ-2016-0268.R1

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  5 in total

1.  Outcomes of cartilage repair techniques for chondral injury in the hip-a systematic review.

Authors:  Naoki Nakano; Chetan Gohal; Andrew Duong; Olufemi R Ayeni; Vikas Khanduja
Journal:  Int Orthop       Date:  2018-03-13       Impact factor: 3.075

2.  Good Outcome Scores and Low Conversion Rate to THA 10 Years After Hip Arthroscopy for the Treatment of Femoroacetabular Impingement.

Authors:  Lorenz Büchler; Valentin Grob; Helen Anwander; Till D Lerch; Pascal C Haefeli
Journal:  Clin Orthop Relat Res       Date:  2021-10-01       Impact factor: 4.755

3.  What the papers say.

Authors:  Ajay Malviya
Journal:  J Hip Preserv Surg       Date:  2017-06-01

4.  Dynamic shear analysis: a novel method to determine mechanical integrity of normal and torn human acetabular labra: Implications for prediction of outcome of repair.

Authors:  A K Woods; J Broomfield; P Monk; F Vollrath; S Glyn-Jones
Journal:  Bone Joint Res       Date:  2018-08-04       Impact factor: 5.853

5.  Periacetabular osteotomy with or without arthroscopic management in patients with hip dysplasia: study protocol for a multicenter randomized controlled trial.

Authors:  Geoffrey P Wilkin; Stéphane Poitras; John Clohisy; Etienne Belzile; Ira Zaltz; George Grammatopoulos; Gerd Melkus; Kawan Rakhra; Tim Ramsay; Kednapa Thavorn; Paul E Beaulé
Journal:  Trials       Date:  2020-08-18       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.